In view of the problems with opting out patents from the Unified Patent Court’s jurisdiction, the court will temporarily accept opt out applications in hard copy in case the CMS ceases to function.…
The European Patent Convention (EPC) is used daily by many patent practitioners and is essential reading for the thousands of candidates taking the European Qualifying Examination (EQE) each year.…
The Unified Patent Court has temporarily restricted non-essential functions of the CMS, in its endeavour to ensure that users who want to file opt-outs can do so within the Sunrise period.
In…
With less than 2 weeks to go before 1 June 2023, it was about time for the UPC to tie several loose ends and to clarify various questions before becoming (more or less) fully operative. Here is an…
The Italian Government has agreed with France and Germany to set up a branch of the central division of the Unified Patent Court in Milan.
This has been announced by the Italian ministry of…
The Unified Patent Court has published an update on the problems with the CMS and the opting out of patents of the jurisdiction of the court before the starting date of 1 June 2023.
On its…
The Unified Patent Court has formally announced that, for the time being, competencies which were originally assigned to the London seat of the UPC central division, will be divided between Munich…
On January 26, 2023, Regeneron Pharmaceuticals, Inc., who sought to invalidate Amgen Inc.’s Japanese patent (JP5705288) covering an isolated monoclonal antibody used as cholesterol medication, won an…
Less than three weeks before the planned opening of the Unified Patent Court, a message has been published on its website as a reaction to problems with the content management system, which…
On 4 May 2023, a mere two weeks after the conclusion of the hearing, the Court of Appeal handed down its decision in Sandoz and Teva v BMS. The appeal decision is centred on the question of…
